Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;63(2):471-500.
doi: 10.1007/s10840-021-01072-1. Epub 2021 Oct 21.

Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article

Affiliations
Review

Effects of opioid receptor agonist and antagonist medications on electrocardiogram changes and presentation of cardiac arrhythmia: review article

Farshid Etaee et al. J Interv Card Electrophysiol. 2022 Mar.

Abstract

Background/purpose: Mortality associated with prescription opioids has significantly increased over the past few decades and is considered a global pandemic. Prescribed opioids can cause cardiac arrhythmias, leading to fatal outcomes and unexpected death, even in the absence of structural cardiac disease. Despite the extent of cardiac toxicity and death associated with these medications, there is limited data to suggest their influences on cardiac electrophysiology and arrhythmias, with the exception of methadone. The goal of our review is to describe the possible mechanisms and to review the different ECG changes and arrhythmias that have been reported.

Methods: A literature search was performed using Google Scholar, PubMed, Springer, Ovid, and Science Direct to identify studies that demonstrated the use of prescription opioids leading to electrocardiogram (ECG) changes and cardiac arrhythmias.

Results: Many of the commonly prescribed opioid medications can uniquely effect the ECG, and can lead to the development of various cardiac arrhythmias. One of the most significant side effects of these drugs is QTc interval prolongation, especially when administered to patients with a baseline risk for QTc prolongation. A prolonged QTc interval can cause lethal torsades de pointes and ventricular fibrillation. Obtaining an ECG at baseline, following a dosage increase, or after switching an opioid medication, is appropriate in patients taking certain prescribed opioids. Opioids are often used first line for the treatment of acute and chronic pain, procedural sedation, medication opioid use disorders, and maintenance therapy.

Conclusions: To reduce the risk of cardiac arrhythmias and to improve patient outcomes, consideration of accurate patient selection, concomitant medications, electrolyte monitoring, and vigilant ECG monitoring should be considered.

Keywords: Cardiac arrhythmia; Electrocardiogram; Opioid agonist; Opioid antagonist; QT prolongation, torsades de pointes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Data Overview | CDC’s response to the opioid overdose epidemic | CDC. Available from: https://www.cdc.gov/opioids/data/index.html .
    1. Opioid Overdose Crisis | National Institute on Drug Abuse (NIDA). Available from: https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-crisis .
    1. Krantz MJ, Palmer RB, Haigney MCP. Cardiovascular complications of opioid use: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;77(2):205–23. - PubMed
    1. Behzadi M, Joukar S, Beik A. Opioids and cardiac arrhythmia: a literature review. Med Princ Pract. 2018;27(5):401–14. - PubMed - PMC
    1. Chugh SS, Socoteanu C, Reinier K, Waltz J, Jui J, Gunson K. A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med. 2008;121(1):66–71. - PubMed - PMC

MeSH terms

LinkOut - more resources